Eli Lilly & Co. (LLY) Misses Q3 EPS by 7c

October 25, 2016 6:26 AM EDT
Get Alerts LLY Hot Sheet
Trade LLY Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $0.88, $0.07 worse than the analyst estimate of $0.95. Revenue for the quarter came in at $5.19 billion versus the consensus estimate of $5.29 billion.

Cialis revenue was $588.2 million. Est. at $594.7 million

Alinta revenue was $570.4 million, est at $551.7 million.

Eli Lilly & Co. reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities

Earnings

Add Your Comment